| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |